GLP-1 Cost Comparison 2026: What Semaglutide and Tirzepatide Actually Cost

If you've searched "GLP-1 cost" recently, you've probably noticed a problem: almost every result is either outdated, deliberately vague, or published by a provider ranking itself first. Prices in the GLP-1 market have shifted dramatically since late 2025, and most comparison content hasn't caught up.

This is a straightforward price comparison. No provider is paying to be ranked higher. We disclose affiliate relationships, note which medications are compounded (and therefore not FDA-approved as finished products), and use current pricing verified against each provider's website.

Brand-Name vs. Compounded: The Price Gap in 2026

The first decision that determines your cost is whether you're taking a brand-name FDA-approved medication or a compounded version. Here's how those categories break down.

Brand-Name GLP-1 Medications

Brand-name options include Wegovy and Ozempic (semaglutide, made by Novo Nordisk) and Zepbound and Mounjaro (tirzepatide, made by Eli Lilly). These are FDA-approved finished products with established safety and efficacy data from large clinical trials.

If your insurance covers GLP-1 medications for weight management — and increasingly, plans do — brand-name is often the most cost-effective route. The copay with a good plan can be as low as $25/month, which is cheaper than any compounded option.

Compounded GLP-1 Medications

Compounded semaglutide and tirzepatide are prepared by licensed pharmacies (503A or 503B facilities) based on individual prescriptions. They use the same active pharmaceutical ingredient but are not FDA-approved as finished products.

Tirzepatide is consistently more expensive to compound than semaglutide because it's a more complex dual-agonist molecule. Expect to pay $50–$150 more per month for compounded tirzepatide versus semaglutide at equivalent providers.

The Hidden Costs Most Comparisons Leave Out

The monthly medication price is only part of what you'll pay. A complete GLP-1 cost comparison needs to account for several additional expenses that add up over a treatment course.

Consultation and Provider Fees

Some providers include telehealth consultations in their monthly price. Others charge separately — typically $50–$150 for an initial visit and $30–$75 for follow-ups. Over 12 months, this can add $200–$600 to your total.

Dose Escalation

This is the cost factor most people miss. Many providers advertise a low starting price at the lowest dose (e.g., 0.25mg semaglutide), but the price increases as your dose goes up. A provider advertising "$149/month" might actually cost $299/month once you reach a therapeutic maintenance dose. Flat-rate providers — where the price stays the same regardless of dose — save significant money over a full treatment course.

Lab Work

Responsible providers require baseline labs (metabolic panel, A1C, thyroid function) and periodic monitoring. If labs aren't included, expect $100–$300 out of pocket, or use your insurance for the lab work separately.

Supplies and Shipping

Most telehealth providers include syringes, alcohol swabs, and shipping. But verify this — some charge $15–$30/month for supplies or a shipping fee per delivery.

How to Find Your Actual Cost

The cheapest GLP-1 path depends entirely on your situation. Here's a quick framework:

If you have commercial insurance: Check your formulary first. If Wegovy or Zepbound is covered, your copay could be $25–$50/month — dramatically cheaper than any compounded option. Call the number on your insurance card and ask specifically about GLP-1 medications for weight management.

If you're paying cash with no insurance: Compounded semaglutide from a reputable telehealth provider will be your most affordable option, typically $149–$250/month. Prioritize flat-rate providers to avoid dose escalation surprises.

If you want tirzepatide specifically: Budget $179–$399/month for compounded tirzepatide. The dual GIP/GLP-1 mechanism shows higher average weight loss in clinical trials (the SURMOUNT program), but the cost premium is real.

If you want brand-name without insurance: Novo Nordisk's self-pay program offers Wegovy at approximately $349/month, and Eli Lilly's LillyDirect offers Zepbound at similar price points. These are competitive with higher-end compounded options while being FDA-approved.

Semaglutide vs. Tirzepatide: Cost Per Pound Lost

Raw monthly cost doesn't tell the whole story. Clinical trial data gives us a way to compare value — though it's important to note that trial results are based on FDA-approved formulations, not compounded versions, and individual results vary significantly.

In head-to-head trials, tirzepatide produced approximately 5–7 percentage points more weight loss than semaglutide. If semaglutide at $179/month helps you lose 15% of your body weight, and tirzepatide at $299/month helps you lose 21%, the "cost per percentage point" is roughly similar — about $12–$14/month per percentage point in both cases.

This isn't a recommendation for one over the other. Your prescribing provider should guide medication selection based on your health profile, not just cost. But the math suggests that tirzepatide's higher price tag may be proportional to its clinical performance for many patients.

What About Oral GLP-1 Options?

Oral semaglutide (Rybelsus) is FDA-approved for type 2 diabetes and is being studied for weight management. Some compounding pharmacies also offer oral semaglutide in formats like sublingual drops, lozenges, and dissolvable tablets. Pricing for compounded oral options ranges from $149–$299/month.

One consideration: FDA-approved oral semaglutide includes a specialized absorption enhancer (SNAC) that most compounded oral versions don't replicate. This means absorption and bioavailability may differ between the FDA-approved oral product and compounded oral alternatives.

Embody offers a unique oral format — a compounded gum containing both semaglutide and tirzepatide — starting at $149 for the first month ($299/month ongoing). It's the only provider we've seen combining both active ingredients in an oral delivery format.

Prices Are Dropping — Here's Why

GLP-1 costs have trended downward through early 2026 for several reasons. Increased competition among telehealth providers has put downward pressure on compounded pricing. Novo Nordisk and Eli Lilly have both introduced self-pay programs that compete more directly with compounded options. And the sheer number of patients entering the market has created scale advantages for larger compounding operations.

Looking ahead, semaglutide patent challenges and potential biosimilar approvals could further disrupt pricing by 2027–2028. International generic manufacturers — particularly in Canada and China — are already producing semaglutide, though these aren't available in the U.S. market yet.

For now, the practical advice is simple: don't lock into long-term contracts at today's prices. Month-to-month plans give you flexibility to switch if a better option appears. And always check your insurance first — the cheapest GLP-1 is the one your plan already covers.